Humacyte (HUMA) Stock Price
$1.68 0%
to add to portfolio
AI Score
-
Alternative
9 -
Fundamental
1 -
Technical
3
Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.
Sign up to get access to more historical data and insights on Humacyte, AI stock picks, stock alerts and much more.
HUMA AI Stock Analysis
AI stock analysis for HUMA is missing at the moment.
Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Humacyte (HUMA) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.
Sign up and become a member to get access to AI stock analysis.
Sign up
Humacyte (HUMA) Price Prediction
Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Humacyte (HUMA), currently trading at $1.68, will... Sign up to access price prediction.
Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.
About HUMA
-
Humacyte, Inc.
-
Symbol
HUMA
-
Market
NASDAQ
-
Industry
Biotechnology
-
Market Cap
260.6M
Similar Stocks
 |
Catalyst Pharmaceuticals CPRX |
$22.52 1.5% |
5 |
 |
Inovio Pharmaceuticals INO |
$1.74 1.2% |
1 |
 |
Moderna MRNA |
$24.72 1.9% |
3 |
 |
Anavex Life Sciences AVXL |
$8.95 1.2% |
5 |
 |
BridgeBio Pharma BBIO |
$33.87 0.1% |
4 |
News
HUMA Alternative Data
Web Traffic
Humacyte receives an estimated 14671 monthly visitors to humacyte.com.
-
Web Traffic
14671
-
Change from Previous Month
26.8%
-
3 Month Change
48.8%
-
YoY Change
48.8%
News Mentions
Humacyte was mentioned 1 times in the news yesterday.
-
News Mentions
1
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
0%
Reddit Mentions
Humacyte has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.
-
Reddit Mentions
0
-
Daily Change
0%
-
1 Month Change
0%
Twitter Followers
Humacyte has 2,099 Twitter Followers on its main Twitter (also known as X) account, which is up by 2.4% over the last month.
-
Twitter Followers
2099
-
Daily Change
0%
-
1 Month Change
2.4%
-
3 Month Change
8.1%
-
YoY Change
8.1%
Facebook Engagement
Humacyte has engaged 61 users via their Facebook Page over the last 7 days.
-
Facebook Engagement
61
-
Daily Change
5.2%
-
1 Month Change
125.9%
-
3 Month Change
69.4%
-
YoY Change
69.4%
Youtube Subscribers
Humacyte has 399 subscribers on its main Youtube channel, up by 1% over the last month.
-
Youtube Subscribers
399
-
Daily Change
0%
-
1 Month Change
1%
-
3 Month Change
0.8%
-
YoY Change
0.8%
LinkedIn Followers
13,332 are following Humacyte on LinkedIn, up by 2.8% over the last month.
-
LinkedIn Followers
13332
-
Daily Change
0%
-
1 Month Change
2.8%
-
3 Month Change
10.3%
Job Postings
Humacyte has an estimated 3 open job postings, which is down -84.2% over the last month.
-
Job Postings
3
-
Daily Change
0%
-
1 Month Change
84.2%
-
3 Month Change
70%
-
YoY Change
70%
LinkedIn Employees
According to LinkedIn, Humacyte has 213 employees.
-
LinkedIn Employees
213
-
Daily Change
0%
-
1 Month Change
0%
-
3 Month Change
1.4%
-
YoY Change
1.4%
Business Outlook
According to employee reviews, the business outlook among employees at Humacyte is 58 out of 100 (neutral).
-
Business Outlook
58
-
Change from Previous Month
10.8%
-
3 Month Change
0%
-
YoY Change
0%
HUMA Financials
HUMA Key Metrics
-
Total Revenue
$7.2M
-
Net Income
$127.8M
-
Earnings per Share
$1.08
-
Free cash flow
-$26.6M
-
EBITDA
$104.5M
-
EBITDA Ratio
14.4634
-
Total Assets
$137.9M
HUMA 2-year Revenue & Income
HUMA 2-year Free Cash Flow
HUMA Technicals
HUMA SMA
HUMA RSI
FAQ
What's the current price of Humacyte (HUMA) Stock?
The price of an Humacyte (HUMA) share is $1.68.
What's the market cap of Humacyte?
The current market cap of Humacyte is 260.6M.
Should I buy or sell HUMA?
Humacyte shows several positive indicators, but they aren’t strong enough to warrant a buy recommendation. At its current price, Humacyte is better viewed as a hold or accumulate position while waiting for further developments.
Is Humacyte a good investment?
The current analysis of Humacyte's fundamentals, technical aspects, and alternative data insights indicates a neutral outlook on the stock. While there are promising elements in Humacyte's portfolio, the presence of equal risks and opportunities suggests that it might not drive significant gains or losses at this moment.
Is now a good time to buy Humacyte (HUMA) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, the outlook for Humacyte stock is currently neutral, suggesting a cautious approach might be wise.
What are some stocks similar to Humacyte (HUMA) that investors often compare it to?
Humacyte (HUMA) is often compared to similar stocks such as Catalyst Pharmaceuticals, Inovio Pharmaceuticals, Moderna, Anavex Life Sciences and BridgeBio Pharma.
What is the forecast for Humacyte's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Humacyte's stock price to be around $1.76 in 2026. Starting from the current price of $1.68, this represents a 4.8% change in price, indicating a neutral outlook for the stock.
How to buy Humacyte (HUMA) Stock?
Humacyte stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Humacyte shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.